Practice Choices in Targeted Intrathecal Drug Delivery: An Online Survey Conducted by the Polyanalgesic Consensus Committee

Abstract

Intrathecal drug delivery (IDD) has evolved over the past 40 years to treat intractable pain and spasticity not successfully managed with other treatment modalities or routes of drug delivery. The overall lack of substantial evidence initially suggested the need for expert review and guidance that led to a series of consensus guidelines from a panel of specialists in conjunction with the International Neuromodulation Society (INS). Beginning in 2000, the Polyanalgesic Consensus Conference (PACC) conducted surveys and published recommendations for appropriate medical practice relating to IDD, with the most recent guidelines published in 2017 (1-15).